Will Adjuvant Oxaliplatin Data Change Practice in CRC?
Dr John Marshall previews the GI cancer studies being presented at ASCO with his picks for the ones to watch, and predicts that a plenary presentation may be practice-changing. (Source: Medscape Oncology)
Source: Medscape Oncology - May 26, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Two 'P' Words Top List of Hot Topics in Breast Cancer
Dr Kathy Miller points to PARP inhibitors and pertuzumab as highpoints of the breast cancer program at the upcoming ASCO meeting, including the plenary presentation of the OlympiAD trial. (Source: Medscape Oncology)
Source: Medscape Oncology - May 26, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Advances in Gynecologic Cancer: ASCO 2017
Dr Markman previews the latest research on gynecologic cancer to be presented at the upcoming ASCO meeting. (Source: Medscape Oncology)
Source: Medscape Oncology - May 26, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Talking With Patients About NGS Testing: Marketing vs Reality
Experts on genomic testing in cancer discuss the marketing of NGS tests, and how they talk to their patients in light of the promise of ‘ precision medicine. ’ (Source: Medscape Oncology)
Source: Medscape Oncology - May 19, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
What's New for Lung Cancer? Stay Tuned for ASCO 2017
From targeted therapy to radiotherapy, Dr Mark Kris previews what ' s ahead for lung cancer management from ASCO 2017. (Source: Medscape Oncology)
Source: Medscape Oncology - May 15, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Expert Panel: Should Genomic Testing Be Broadly Used in Cancer?
Experts respond to a Medscape survey of oncologists on the limits of genomic testing in cancer care. (Source: Medscape Oncology)
Source: Medscape Oncology - May 15, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
New Approaches Needed for Peritoneal Metastases in CRC
Dr David Kerr challenges the oncology community to come up with rational, meaningful clinical trials to clarify the biology of metastatic peritoneal disease in colorectal cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - April 13, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Antineoplastic Agents in Breast Cancers With Mutational Signatures
Dr Markman encourages review of recently reported possible effect of ovarian cancer antineoplastic agents in breast cancer patients with rare BRCA mutational signatures. (Source: Medscape Oncology)
Source: Medscape Oncology - April 12, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
